EUSA Pharma (UK) Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
300
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
- Investments
-
5
EUSA Pharma (UK) General Information
Description
Operator of a specialty pharmaceutical company specializing in oncology and other critical diseases. The company offers biopharmaceutical products focused on rare diseases, for the treatment of oral mucositis, a common and debilitating side-effect of radiotherapy and high-dose chemotherapy, thereby enabling patients to cure their problems with effective treatment.
Contact Information
Website
www.eusapharma.com(Operating Subsidiary)
Corporate Office
- Breakspear Park
- Breakspear Way
- Hemel Hempstead HP2 4TZ
- England, United Kingdom
Corporate Office
- Breakspear Park
- Breakspear Way
- Hemel Hempstead HP2 4TZ
- England, United Kingdom
EUSA Pharma (UK) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EUSA Pharma (UK) Comparisons
Industry
Financing
Details
EUSA Pharma (UK) Competitors (8)
One of EUSA Pharma (UK)’s 8 competitors is Astex Pharmaceuticals, a Corporate Backed or Acquired company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Astex Pharmaceuticals | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Karyopharm Therapeutics | Formerly VC-backed | Newton, MA | ||||
| Amryt Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Veru | Corporation | Miami, FL |
EUSA Pharma (UK) Patents
EUSA Pharma (UK) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2008151226-A1 | Treatment of vertebral cancer with 153 samarium | Inactive | 04-Jun-2007 | ||
| WO-2008153802-A1 | Ex-vivo treatment of cancer using psma and antibodies thereto | Inactive | 29-May-2007 |
EUSA Pharma (UK) Signals
EUSA Pharma (UK) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
EUSA Pharma (UK) Investments (5)
EUSA Pharma (UK)’s most recent deal was a Buyout/LBO with Sylvant for . The deal was made on 01-Jul-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sylvant | 01-Jul-2018 | Buyout/LBO | Buildings and Property | ||
| Apeiron Biologics (dinutuximab beta) | 04-Oct-2016 | Buyout/LBO | Buildings and Property | ||
| Arcoral Pharma (Arcoral Tab) | 12-Apr-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Cytogen | 08-May-2008 | Buyout/LBO | Pharmaceuticals | ||
| OPi | 22-Mar-2007 | Buyout/LBO | Biotechnology |
EUSA Pharma (UK) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Eusa Pharma (Denmark) | Hellerup, Denmark | 2017 | |
| Recordati Netherlands | Schipholrijk, Netherlands | 2015 |
EUSA Pharma (UK) FAQs
-
When was EUSA Pharma (UK) founded?
EUSA Pharma (UK) was founded in 2006.
-
Where is EUSA Pharma (UK) headquartered?
EUSA Pharma (UK) is headquartered in Hemel Hempstead, United Kingdom.
-
What is the size of EUSA Pharma (UK)?
EUSA Pharma (UK) has 300 total employees.
-
What industry is EUSA Pharma (UK) in?
EUSA Pharma (UK)’s primary industry is Pharmaceuticals.
-
Is EUSA Pharma (UK) a private or public company?
EUSA Pharma (UK) is a Private company.
-
What is the current valuation of EUSA Pharma (UK)?
The current valuation of EUSA Pharma (UK) is .
-
What is EUSA Pharma (UK)’s current revenue?
The current revenue for EUSA Pharma (UK) is .
-
How much funding has EUSA Pharma (UK) raised over time?
EUSA Pharma (UK) has raised $151M.
-
Who are EUSA Pharma (UK)’s investors?
3i Group, Advent Life Sciences, Advent Venture Partners, Alexandra Investment Management, and Alpha Leonis Partners are 5 of 22 investors who have invested in EUSA Pharma (UK).
-
Who are EUSA Pharma (UK)’s competitors?
Astex Pharmaceuticals, Karyopharm Therapeutics, Amryt Pharma, Verona Pharma, and Veru are some of the 8 competitors of EUSA Pharma (UK).
-
When was EUSA Pharma (UK) acquired?
EUSA Pharma (UK) was acquired on 16-Mar-2022.
-
Who acquired EUSA Pharma (UK)?
EUSA Pharma (UK) was acquired by Recordati.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process